Initial Workup and Management of Splenic Infarction
The initial workup for a patient with suspected splenic infarction should include contrast-enhanced CT scan as the gold standard for diagnosis, followed by comprehensive evaluation for underlying causes such as hematologic disorders, cardioembolic conditions, and collagen vascular diseases, with management focused on hemodynamic monitoring and supportive care. 1
Diagnostic Approach
Initial Assessment
- Assess hemodynamic stability (systolic blood pressure ≥90 mmHg without signs of skin vasoconstriction, altered consciousness, or shortness of breath) 1
- Evaluate for left upper quadrant abdominal pain, fever, and constitutional symptoms, which are present in approximately 80% of patients with splenic infarction 2
- Perform physical examination with particular attention to left upper quadrant tenderness, which is present in about 35% of cases 2
Imaging Studies
- Obtain contrast-enhanced CT scan as the primary diagnostic modality for suspected splenic infarction 1
- Consider Doppler ultrasound (DUS) and contrast-enhanced ultrasound (CEUS) as adjunctive studies, though ultrasound is diagnostic in only 18% of cases 1, 2
- Look for characteristic wedge-shaped hypodense lesions on CT that do not enhance with contrast 1
Laboratory Evaluation
- Complete blood count to assess for underlying hematologic disorders 3
- Coagulation profile to evaluate for hypercoagulable states 4
- Blood cultures if infectious etiology or endocarditis is suspected 5
- Cardiac biomarkers if cardioembolic source is suspected 6
Etiologic Workup
Hematologic Disorders
- Evaluate for hematologic conditions, which account for approximately 59% of splenic infarctions 3
- Screen for myeloproliferative disorders, particularly those with hyperleukocytosis and thrombocytosis 4
- Consider hemoglobinopathies, especially sickle cell disease 3
Thromboembolic Disorders
- Assess for cardiac sources of emboli, particularly atrial fibrillation, valvular heart disease, and endocarditis 6
- Consider echocardiography (transthoracic or transesophageal) to identify cardiac sources of emboli 6, 5
- Evaluate for atherosclerotic disease, especially in older patients 6
Management Protocol
Initial Management
- Admit patients to an institution with 24/7 capacity to perform emergency interventions 1
- Provide continuous monitoring for at least the first 24 hours in an intensive care unit 1
- Implement clinical and laboratory observation for a minimum of 3-5 days 1
- Maintain bed rest for the first 48-72 hours in patients with uncomplicated splenic infarction 1
Supportive Care
- Administer appropriate analgesia for pain control 4
- Provide intravenous fluid hydration as needed 4
- Monitor vital signs and abdominal examination findings regularly 1
- Perform serial laboratory tests to track inflammatory markers and hematologic parameters 1
Treatment of Underlying Cause
- Initiate anticoagulation therapy if cardioembolic source is identified, balancing thrombotic and bleeding risks 4
- Treat underlying hematologic disorders with appropriate disease-specific therapy 4
- Consider antibiotics if infectious etiology is suspected, particularly in cases of endocarditis 5
Monitoring and Follow-up
- Perform serial clinical examinations and laboratory monitoring throughout hospitalization 1
- Consider repeat CT scan before hospital discharge and/or when complications are suspected 1
- Monitor for potential complications including splenic rupture, hemorrhage, and abscess formation 3
- Assess for abdominal compartment syndrome, which can be a complication of splenic infarction 1
Indications for Surgical Intervention
- Consider surgical intervention in patients who develop complications such as splenic rupture, hemorrhage, or abscess 1
- Evaluate for splenectomy in cases of persistent symptoms or complications despite medical management 3
- Surgical management is indicated in patients with hemodynamic instability due to splenic complications 7
Special Considerations
- Be aware that splenic infarction may be the presenting symptom of potentially fatal underlying diseases in approximately 16.6% of cases 2
- Patients with non-malignant hematologic conditions may be asymptomatic in up to 55% of cases 3
- Fever is especially common in patients with embolic conditions (70%) 3